Search Results - "Jørgensen, Casper H"

Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study by AHLEHOFF, Ole, GISLASON, Gunnar H, JØRGENSEN, Casper H, LINDHARDSEN, Jesper, CHARLOT, Mette, OLESEN, Jonas B, ABILDSTRØM, Steen Z, SKOV, Lone, TORP-PEDERSEN, Christian, HANSEN, Peter Riis

“…Psoriasis is a chronic inflammatory disease and inflammation contributes to the pathogenesis of atrial fibrillation (AF) and ischaemic stroke. We therefore…”
Get full text

Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study by Charlot, Mette, Ahlehoff, Ole, Norgaard, Mette Lykke, Jørgensen, Casper H, Sørensen, Rikke, Abildstrøm, Steen Z, Hansen, Peter Riis, Madsen, Jan Kyst, Køber, Lars, Torp-Pedersen, Christian, Gislason, Gunnar

“…Controversy remains on whether the dual use of clopidogrel and proton-pump inhibitors (PPIs) affects clinical efficacy of clopidogrel. To examine the risk for…”
Get full text

Heart failure severity, as determined by loop diuretic dosages, predicts the risk of developing diabetes after myocardial infarction: a nationwide cohort study by Andersson, Charlotte, Norgaard, Mette L., Hansen, Peter R., Fosbøl, Emil L., Schmiegelow, Michelle, Weeke, Peter, Olesen, Jonas B., Raunsø, Jakob, Jørgensen, Casper H., Vaag, Allan, Køber, Lars, Torp-Pedersen, Christian, Gislason, Gunnar H.

“…Aims Heart failure (HF) is associated with increased insulin resistance, but the consequences of HF for development of diabetes are not well studied. The aim…”
Get full text

Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention--a retrospective nationwide cohort study by Jørgensen, Casper H, Gislason, Gunnar H, Andersson, Charlotte, Ahlehoff, Ole, Charlot, Mette, Schramm, Tina K, Vaag, Allan, Abildstrøm, Steen Z, Torp-Pedersen, Christian, Hansen, Peter R

“…The optimum oral pharmacological treatment of diabetes mellitus to reduce cardiovascular disease and mortality following myocardial infarction has not been…”
Get full text

Comparable long-term mortality risk associated with individual sulfonylureas in diabetes patients with heart failure by Andersson, Charlotte, Gislason, Gunnar H, Jørgensen, Casper H, Hansen, Peter R, Vaag, Allan, Sørensen, Rikke, Mérie, Charlotte, Olesen, Jonas B, Weeke, Peter, Schmiegelow, Michelle, Norgaard, Mette L, Køber, Lars, Torp-Pedersen, Christian

“…Abstract Aims The aim was to investigate the outcomes of individual sulfonylureas in patients with heart failure (HF). Methods All patients hospitalized with…”
Get full text

Use of secondary prevention pharmacotherapy after first myocardial infarction in patients with diabetes mellitus by Jørgensen, Casper H, Gislason, Gunnar H, Ahlehoff, Ole, Andersson, Charlotte, Torp-Pedersen, Christian, Hansen, Peter R

“…Despite recommended pharmacotherapies the use of secondary prevention therapy after myocardial infarction (MI) remains suboptimal. Patients with diabetes…”
Get full text

PSORIASIS IS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND PERCUTANEOUS CORONARY INTERVENTION: A DANISH NATIONWIDE COHORT STUDY by Ahlehoff, Ole, Gislason, Gunnar H, Lindhardsen, Jesper, Jorgensen, Casper H, Charlot, Mette G, Abildstrom, Steen Z, Skov, Lone, Torp-Pedersen, Christian, Hansen, Peter R

Get full text

PROTON PUMP INHIBITORS ARE ASSOCIATED WITH CARDIOVASCULAR RISK INDEPENDENT OF CLOPIDOGREL USE IN PATIENTS WITH MYOCARDIAL INFARCTION: A NATIONWIDE PROPENSITY SCORE MATCHED STUDY by Charlot, Mette G, Ahlehoff, Ole, Jorgensen, Casper H, Abildstrom, Steen Z, Køber, Lars, Hansen, Peter R, Torp-Pedersen, Christian, Gislason, Gunnar

Get full text

PSORIASIS IS A RISK FACTOR FOR ATRIAL FIBRILLATION AND STROKE: A DANISH NATIONWIDE COHORT STUDY by Ahlehoff, Ole, Gislason, Gunnar H, Lindhardsen, Jesper, Jorgensen, Casper H, Charlot, Mette G, Abildstrom, Steen Z, Skov, Lone, Torp-Pedersen, Christian, Hansen, Peter R

Get full text

EFFECTS OF ORAL GLUCOSE-LOWERING DRUGS ON LONG TERM OUTCOMES IN PATIENTS WITH DIABETES MELLITUS AND NON-ST ELEVATION MYOCARDIAL INFARCTION by Jorgensen, Casper H, Gislason, Gunnar H, Andersson, Charlotte, Ahlehoff, Ole, Charlot, Mette G, Abildstrom, Steen Z, Vaag, Allan, Torp-Pedersen, Christian, Hansen, Peter R

Get full text